US20090324689A1 - Transscleral delivery - Google Patents

Transscleral delivery Download PDF

Info

Publication number
US20090324689A1
US20090324689A1 US12/541,085 US54108509A US2009324689A1 US 20090324689 A1 US20090324689 A1 US 20090324689A1 US 54108509 A US54108509 A US 54108509A US 2009324689 A1 US2009324689 A1 US 2009324689A1
Authority
US
United States
Prior art keywords
rapamycin
method
therapeutic agent
eye
polymer implant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/541,085
Inventor
Eugene R. Cooper
David M. Kleinman
Thierry Nivaggioli
Philippe J. M. Dor
Sreenivasu Mudumba
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
MacuSight Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US50384003P priority Critical
Priority to US10/945,682 priority patent/US7585517B2/en
Application filed by MacuSight Inc filed Critical MacuSight Inc
Priority to US12/541,085 priority patent/US20090324689A1/en
Assigned to MACUSIGHT, INC. reassignment MACUSIGHT, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KLEINMAN, DAVID M., COOPER, EUGENE R., DOR, PHILIPPE JM, MUDUMBA, SREENIVASU, NIVAGGIOLI, THIERRY
Publication of US20090324689A1 publication Critical patent/US20090324689A1/en
Assigned to SANTEN PHARMACEUTICAL CO., LTD. reassignment SANTEN PHARMACEUTICAL CO., LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MACUSIGHT, INC.
Application status is Abandoned legal-status Critical

Links